Physical activity, quality of life and cardiovascular risk score
SIT, coronary artery disease
HEART, CORONARY ARTERY DISEASE
Time spent in LIPA, MVPA and step count increased from pre- to post-CR in both the SIT LESS (Δ LIPA: 1.3 (95% CI 0.9; 1.8); Δ MVPA: 0.3 (95% CI 0.2; 0.5) hours/day; Δ step count: 2969 (95% CI 2102; 3836) steps/day) and control group (Δ LIPA: 1.1 (95% CI 0.7; 1.5); Δ MVPA: 0.4 (95% CI 0.3; 0.5) hours/day; Δ step count: 3086 (95% CI 2180; 3992) steps/day). However, the magnitude of these improvements was not significantly different between SIT LESS and controls for LIPA time (0.2 (95% CI ─0.3; 0.8 h/day); MVPA time (0.0 (95% CI ─0.2; 0.1 h/day); and step count (− 117 (95% CI − 1367; 1134 steps/day) (Fig. Physical activity outcomes of the SIT LESS randomised clinical trial in patients with coronary artery disease pre- and post-cardiac rehabilitation (CR). Scatter plots with median and interquartile range of light-intensity physical activity (LIPA, panelQuality of life, patients’ competencies for self-management and cardiovascular risk outcomes of the SIT LESS randomised clinical trial in patients with coronary artery disease pre- and post-cardiac rehabilitation (CR). Scatter plots with median and interquartile range of Heart quality of life (HeartQoL) score (panel 